Cargando…

Telomerase activation in nasopharyngeal carcinomas.

Nasopharyngeal carcinomas (NPC) are common in Hong Kong and southern China but rare in Western countries. Telomerase activation is common in human cancers but has not been reported previously in NPC. Telomerase activation in NPC was determined using the sensitive TRAP (telomerase rapid amplification...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, R. Y., Yuen, P. W., Nicholls, J. M., Zheng, Z., Wei, W., Sham, J. S., Yang, X. H., Cao, L., Huang, D. P., Tsao, S. W.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1998
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151288/
https://www.ncbi.nlm.nih.gov/pubmed/9472643
_version_ 1782144717354434560
author Cheng, R. Y.
Yuen, P. W.
Nicholls, J. M.
Zheng, Z.
Wei, W.
Sham, J. S.
Yang, X. H.
Cao, L.
Huang, D. P.
Tsao, S. W.
author_facet Cheng, R. Y.
Yuen, P. W.
Nicholls, J. M.
Zheng, Z.
Wei, W.
Sham, J. S.
Yang, X. H.
Cao, L.
Huang, D. P.
Tsao, S. W.
author_sort Cheng, R. Y.
collection PubMed
description Nasopharyngeal carcinomas (NPC) are common in Hong Kong and southern China but rare in Western countries. Telomerase activation is common in human cancers but has not been reported previously in NPC. Telomerase activation in NPC was determined using the sensitive TRAP (telomerase rapid amplification protocol) assay in 45 nasopharyngeal biopsies (36 NPC, nine normal nasopharyngeal mucosae) in four xenografted NPC tumours established in nude mice and in five in vitro NPC cell lines. Telomerase activation is common in NPC and can be detected at high frequencies (85% in primary tumours and 100% in recurrent tumours). The frequency of telomerase activation was lowest in NPC biopsies without lymph node involvement (60%) compared with those with positive lymph node involvement (100%), and the difference is statistically significant (P < 0.05; Fisher exact test). All the xenografted NPC tumours and in vitro NPC cell lines were strongly positive for telomerase activity. Our results suggest that telomerase activation is common in NPC and it may be useful as a diagnostic marker in the detection of tumour cells in nasopharyngeal biopsies. The high frequency of telomerase activation in stage I NPC (80% positive) suggests that it is an early event in tumour progression. IMAGES:
format Text
id pubmed-2151288
institution National Center for Biotechnology Information
language English
publishDate 1998
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-21512882009-09-10 Telomerase activation in nasopharyngeal carcinomas. Cheng, R. Y. Yuen, P. W. Nicholls, J. M. Zheng, Z. Wei, W. Sham, J. S. Yang, X. H. Cao, L. Huang, D. P. Tsao, S. W. Br J Cancer Research Article Nasopharyngeal carcinomas (NPC) are common in Hong Kong and southern China but rare in Western countries. Telomerase activation is common in human cancers but has not been reported previously in NPC. Telomerase activation in NPC was determined using the sensitive TRAP (telomerase rapid amplification protocol) assay in 45 nasopharyngeal biopsies (36 NPC, nine normal nasopharyngeal mucosae) in four xenografted NPC tumours established in nude mice and in five in vitro NPC cell lines. Telomerase activation is common in NPC and can be detected at high frequencies (85% in primary tumours and 100% in recurrent tumours). The frequency of telomerase activation was lowest in NPC biopsies without lymph node involvement (60%) compared with those with positive lymph node involvement (100%), and the difference is statistically significant (P < 0.05; Fisher exact test). All the xenografted NPC tumours and in vitro NPC cell lines were strongly positive for telomerase activity. Our results suggest that telomerase activation is common in NPC and it may be useful as a diagnostic marker in the detection of tumour cells in nasopharyngeal biopsies. The high frequency of telomerase activation in stage I NPC (80% positive) suggests that it is an early event in tumour progression. IMAGES: Nature Publishing Group 1998 /pmc/articles/PMC2151288/ /pubmed/9472643 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Cheng, R. Y.
Yuen, P. W.
Nicholls, J. M.
Zheng, Z.
Wei, W.
Sham, J. S.
Yang, X. H.
Cao, L.
Huang, D. P.
Tsao, S. W.
Telomerase activation in nasopharyngeal carcinomas.
title Telomerase activation in nasopharyngeal carcinomas.
title_full Telomerase activation in nasopharyngeal carcinomas.
title_fullStr Telomerase activation in nasopharyngeal carcinomas.
title_full_unstemmed Telomerase activation in nasopharyngeal carcinomas.
title_short Telomerase activation in nasopharyngeal carcinomas.
title_sort telomerase activation in nasopharyngeal carcinomas.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2151288/
https://www.ncbi.nlm.nih.gov/pubmed/9472643
work_keys_str_mv AT chengry telomeraseactivationinnasopharyngealcarcinomas
AT yuenpw telomeraseactivationinnasopharyngealcarcinomas
AT nichollsjm telomeraseactivationinnasopharyngealcarcinomas
AT zhengz telomeraseactivationinnasopharyngealcarcinomas
AT weiw telomeraseactivationinnasopharyngealcarcinomas
AT shamjs telomeraseactivationinnasopharyngealcarcinomas
AT yangxh telomeraseactivationinnasopharyngealcarcinomas
AT caol telomeraseactivationinnasopharyngealcarcinomas
AT huangdp telomeraseactivationinnasopharyngealcarcinomas
AT tsaosw telomeraseactivationinnasopharyngealcarcinomas